Ilsung Pharm (003120) — Cash Flow Reinvestment Rate
Ilsung Pharm (003120) has a Cash Flow Reinvestment Rate of 0.56x as of June 2025, reinvesting ₩2.89 Billion (capex ₩395.62 Million plus investments ₩-2.50 Billion) from operating cash flow of ₩5.13 Billion. Check Ilsung Pharm cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ilsung Pharm Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Ilsung Pharm across 9 annual periods. Explore 003120 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Ilsung Pharm (2013–2025)
Year-by-year capital reinvestment analysis for Ilsung Pharm. For live market cap and broader valuation context, see 003120 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.26x | ₩8.79 Billion | ₩3.88 Billion | ₩2.18 Billion | ▼ -59.9% |
| 2021 | 5.65x | ₩32.21 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +25.1% |
| 2020 | 4.52x | ₩7.03 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -11.7% |
| 2019 | 5.11x | ₩22.44 Billion | ₩4.39 Billion | ₩1.24 Billion | ▲ +540.5% |
| 2018 | 0.80x | ₩12.05 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +96.7% |
| 2017 | 0.41x | ₩4.12 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -58.5% |
| 2015 | 0.98x | ₩5.91 Billion | ₩6.04 Billion | ₩2.85 Billion | ▼ -37.6% |
| 2014 | 1.57x | ₩6.57 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +222.5% |
| 2013 | 0.49x | ₩2.46 Billion | ₩5.06 Billion | ₩1.13 Billion | — |